Medizin
Refine
Year of publication
- 2014 (245) (remove)
Document Type
- Article (219)
- Part of Periodical (8)
- Doctoral Thesis (7)
- Book (6)
- Conference Proceeding (3)
- Contribution to a Periodical (1)
- Periodical (1)
Language
- English (214)
- German (29)
- Multiple languages (1)
- Romanian (1)
Is part of the Bibliography
- no (245)
Keywords
- Multimorbidity (4)
- Depression (3)
- Primary care (3)
- ATM (2)
- Aortic valve replacement (2)
- Cancer (2)
- Chronic disease (2)
- Decorin (2)
- Family practice (2)
- General practice (2)
- HER2 (2)
- IR-A (2)
- Inflammation (2)
- Outcome (2)
- Proliferation (2)
- Signaling (2)
- apoptosis (2)
- 1α,25(OH)2D3 (1)
- 4-1BB (1)
- 99mTc-MIBI (1)
- 99mTc-pertechnetate (1)
- A/D transition (1)
- ABCB1 (1)
- ABCC1 (1)
- ABCG2 (1)
- ARID5B (1)
- Accelerometry (1)
- Acquired drug resistance (1)
- Adult T-cell acute lymphoblastic leukemia (1)
- Advanced biliary tract cancer (1)
- Agreement (1)
- All oral (1)
- Allograft bone block (1)
- Alpha-synuclein (1)
- Alzheimer (1)
- Amyloid precursor protein (1)
- Aneurysm (1)
- Angiogenesis (1)
- Anopheles (1)
- Anti-TNF (1)
- Aortic valve (1)
- Assessment of care (1)
- Auditory (1)
- Autogenous bone block (1)
- Autonomic nervous system (1)
- BCL11b (1)
- BPDCN (1)
- BTC (1)
- Biological heart valves (1)
- Biological markers (1)
- Biomarker (1)
- Bioprosthesis (1)
- Bipolar (1)
- Bipolar disorder (1)
- Bone regeneration (1)
- Breast cancer (1)
- CD137 (1)
- CD8+ T-cell mediated tumor suppression (1)
- CDKN2A (1)
- CEBPE (1)
- CV9202 (1)
- CY-503 (1)
- Cancer staging (1)
- Cardiac function (1)
- Cardiovascular mortality (1)
- Carrier-bound fibrin sealant (1)
- Causality assessment (1)
- Cell cycle (1)
- Cell plasticity (1)
- Cell proliferation (1)
- Cellular (1)
- Cerebellar ataxia (1)
- Chemokine CCL2 (1)
- Chemokines (1)
- Chromoendoscopy (1)
- Chronic Hepatitis C (1)
- Chronic care model (1)
- Chronic diseases (1)
- Chronic medical conditions (1)
- Chronic pancreatitis (1)
- Citationrate (1)
- Clinical studies (1)
- Clinical trial (1)
- Cluster randomization (1)
- Coexistence (1)
- Collagen hemostat (1)
- Collagen type I (1)
- Collagen type III (1)
- Colorectal cancer (1)
- Comorbidity (1)
- Complex I (1)
- Complexin-1 (1)
- Confocal endomicroscopy (1)
- Conformational change (1)
- Coping (1)
- Creeping Disease (1)
- Cross-sectional (1)
- Cytoskeletal proteins (1)
- D2-autoreceptor (1)
- DAA (1)
- DKTK-ROG (1)
- DMARDs (biologic) (1)
- DNA damage (1)
- DNA mismatch repair (1)
- DTI (1)
- Daptomycin (1)
- Dataset bias (1)
- Decision making (1)
- Dendritic cells (1)
- Density-equalizing mapping (1)
- Diabetes mellitus (1)
- Diagnosis (1)
- Diagnostik (1)
- Dicer (1)
- Diffuse large B cell lymphoma (1)
- Direct-acting antiviral agents (DAAs) (1)
- Disease Activity (1)
- Drug (1)
- Drug development (1)
- Drug hepatotoxicity (1)
- Drug induced liver injury (1)
- EBM (1)
- EGFR (1)
- EQ-5D (1)
- ES cells (1)
- Elderly patients (1)
- Electrical instability (1)
- Electronic cigarettes (1)
- Endometrial cancer (1)
- Endoscopic retrograde Cholangiopancreatography (ERCP) (1)
- Endothelial cells (1)
- Ethnicity (1)
- Everolimus resistance (1)
- Evidenzbasierte Medizin (1)
- Exercise testing (1)
- Expression (1)
- FSS (1)
- Fbw7 (1)
- Fibroblasts (1)
- Fingolimod (1)
- Foxp1 (1)
- Frontotemporal dementia (1)
- Functionally-impaired elderly (1)
- GM-CSF (1)
- GRADE (1)
- Gastric cancer (1)
- Gene expression (1)
- Gene-protein assay (1)
- GeneMANIA (1)
- Genetics (1)
- Geschlechtsdysphorie bei Kindern und Jugendlichen (1)
- Geschlechtsidentitätsstörungen im Kindes- und Jugendalter (1)
- Glucocorticoids (1)
- Goal-oriented care (1)
- Guided tissue regeneration (1)
- H-Index (1)
- H5N1 (1)
- HDAC (1)
- HDAC-inhibition (1)
- HNSCC (1)
- HPV (1)
- Hamburg <2014> (1)
- Hand-foot syndrome (1)
- Hard-to-reach population (1)
- Health care access (1)
- Health services research (1)
- Health-related quality of life (1)
- Hemostatics (1)
- Herb induced liver injury (1)
- Herbal hepatotoxicity (1)
- Hif-1 alpha (1)
- Hif1α (1)
- High-density lipoprotein (1)
- Hippocampus (1)
- Host-targeting agents (HTAs) (1)
- IBD (1)
- IKZF1 (1)
- IL-12 (1)
- Immunohistochemistry (1)
- In vitro (1)
- Infant leukemia (1)
- Infants (1)
- Infektionsabwehr (1)
- Inner ear therapy (1)
- Insulin therapy (1)
- Interferon-free HCV treatment (1)
- Intratympanic drug delivery (1)
- KRAS (1)
- Katamnese Transidentität im Kindes- und Jugendalter (1)
- Knockout (1)
- Kongress (1)
- LHRH receptor (1)
- LUBAC (1)
- LVAD (1)
- Leitlinie (1)
- Lipid trafficking (1)
- Liver resection (1)
- Long term result (1)
- Long-term follow up (1)
- Longitudinal analysis (1)
- Low-dose X-irradiation (1)
- Lymphangiogenesis (1)
- MCAK (1)
- MEG (1)
- MKP1 (1)
- MLH1 (1)
- MLL (1)
- MMP9 (1)
- MPM (1)
- MRSA (1)
- Maintenance treatment (1)
- Mania (1)
- Mcl-1 (1)
- Medizinische Ausbildung (1)
- Melanoma (1)
- Menthol (1)
- Metastatic breast cancer (1)
- Microarray (1)
- Midbrain/brainstem expression changes (1)
- Migrants (1)
- Mitoxantrone (1)
- Motor neuron disease (1)
- Multidetector computed tomography (1)
- Mutation (1)
- Myelin or myeloarchitecture (1)
- Myeloperoxidase (1)
- Myotonic dystrophy (1)
- N-acetyl-L-cysteine (1)
- N-hydroxysuccinimide (1)
- NADH:ubiquinone oxidoreductase (1)
- NFAT (1)
- NFκB (1)
- NKG2D (1)
- NRAS (1)
- NS3/4A protease inhibitors (PI) (1)
- NS5A inhibitors (1)
- Neoplasms (1)
- Neuronal morphology (1)
- Nicotine (1)
- Nodular lymphocyte predominant Hodgkin lymphoma (1)
- Non-aneurysmal (1)
- Non-nucleoside polymerase inhibitors (NNI) (1)
- Non-perimesencephalic (1)
- Observational study (1)
- Oral anticoagulation (1)
- Oxygen uptake (1)
- PDCD4 (1)
- PDGFRβ (1)
- PLX4032 (1)
- PLX4720 (1)
- PROMISE (1)
- PTEN (1)
- Paediatric Investigation Plan (1)
- Paediatric oncology (1)
- Pain (1)
- Parkinsons disease (1)
- Parkinson’s disease (1)
- Patient care planning (1)
- Patient preference (1)
- Patient-centered care (1)
- Patient-centred care (1)
- Patients (1)
- Perilymph (1)
- Perimesencephalic (1)
- Phase 2 (1)
- Physician report (1)
- Pink esthetic score (1)
- Plasma (1)
- Plasmodium (1)
- Plastic endoprosthesis (1)
- Plk1 (1)
- Plk1 inhibitors (1)
- Polarity index (1)
- Pooling (1)
- Postoperative radiochemotherapy (1)
- Precompetitive development (1)
- Predominant polarity (1)
- Prepontine (1)
- Presynaptic vesicles (1)
- Prostatic neoplasms (1)
- Protein tyrosine modification (1)
- QA/QC (1)
- Quality of life (1)
- Quantitative MRI (1)
- Questionnaire (1)
- RNA interference (1)
- RNA processing machinery (1)
- RNActive (1)
- ROS (1)
- Radiotherapy (1)
- Randomized controlled trial (1)
- Reconstruction (1)
- Regeneration (1)
- Regulatory framework (1)
- Renal cell carcinoma (1)
- Resting state (1)
- Rheumatoid Arthritis (1)
- Risk factor (1)
- Risk stratification (1)
- Round window membrane (1)
- SAH close (1)
- SOD (1)
- SPTAN1 (1)
- STAT5 (1)
- Sauerstoffpartialdruck (1)
- Schizophrenia (1)
- Scientometria (1)
- Selenium (1)
- Selenoproteins (1)
- Self-assessment (1)
- Self-expandable metal stent (SEMS) (1)
- Self-report (1)
- Sharpin (1)
- Silicosis (1)
- Silver in situ hybridization (1)
- Social support (1)
- Sorafenib (1)
- Source reconstruction (1)
- Sphingosine-1-phosphate (1)
- Spine density (1)
- Standard risk (1)
- Subarachnoid hemorrhage (1)
- Sudden cardiac death (1)
- Supplementation (1)
- Survival analysis (1)
- TIA-1 (1)
- TMC435 (1)
- TNFR1 (1)
- TRAIL (1)
- Targeted therapy (1)
- Th1 polarization (1)
- Therapie (1)
- Thyroid disease (1)
- Tissue engineering (1)
- Tracheal Intubation (1)
- Transcatheter based aortic valve implantation (1)
- Transcriptome (1)
- Transformation (1)
- Transidente Kinder und Jugendliche (1)
- Trastuzumab (1)
- Triamcinolone acetonide (1)
- Tumor growth (1)
- Tumor microenvironment (1)
- Ureter (1)
- Urothelial cells (1)
- VBM (1)
- VDR (1)
- VEGFR (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vein (1)
- Veino-lymphatic separation (1)
- Vemurafenib (1)
- Video (1)
- Videolaryngoscopy (1)
- Vincristine (1)
- Wundheilung (1)
- ablation techniques (1)
- acute attacks (1)
- acute lung injury (1)
- adaptive immune escape (1)
- adenovirus (1)
- adipose-derived stem cells (ASCs) (1)
- adjuvant chemotherapy (1)
- aging (1)
- albumin (1)
- amphiregulin (1)
- antitumor immunity (1)
- antiviral (1)
- apixaban (1)
- arsenic trioxide (1)
- arterial hypertension (1)
- astroglia (1)
- ataxia telangiectasia (1)
- aviscumine (1)
- baicalein (1)
- baroreflex (1)
- bibliometry (1)
- biochanin A (1)
- blastic plasmacytoid dendritic cell neoplasm (1)
- brain metastasis (1)
- breast (1)
- burden of illness (1)
- c-kit (1)
- cancer immunotherapy (1)
- carbapenemase (1)
- cardiovascular pharmacology (1)
- cdk2/cyclin A (1)
- cell biology (1)
- cell fate (1)
- cell identity (1)
- chemokines (1)
- chromosome alignment (1)
- chronic liver disease (CLD) (1)
- cigarette (1)
- citation (1)
- climate change (1)
- clinico-biological indices (1)
- cocaine (1)
- collaborative feedback (1)
- colloid (1)
- common neighbor (1)
- complex systems (1)
- comprehensive care (1)
- computerized programs (1)
- cone-beam computed tomography (CBCT) (1)
- cortex (1)
- cortical networks (1)
- cortical slices (1)
- cross-border (1)
- cross-communication (1)
- crystalloid (1)
- cyclooxygenase (1)
- cytotoxic immunotherapy (1)
- dabigatran (1)
- dendritic cell–tumor cell fusion (1)
- denervation (1)
- differentiation (1)
- distributed computation (1)
- edoxaban (1)
- education (1)
- educational theory (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- endothelin (1)
- endothelin receptor type A antagonist (1)
- environment (1)
- epidemiology (1)
- epigenetic memory (1)
- epigenetics (1)
- epiregulin (1)
- erythropoietin (1)
- faculty development (1)
- fatigue (1)
- fluid (1)
- follow-up study of transidentity in children and adolescents (1)
- full-contour zirconia (1)
- gender studies (1)
- gene expression (1)
- glioma (1)
- gram-negative bacteria (1)
- graph theory (1)
- grinding (1)
- guanidine alkaloid (1)
- guideline (1)
- healthcare personnel (1)
- heart failure (1)
- hepatitis C virus (1)
- hepatocellular carcinoma (HCC) (1)
- hereditary angioedema (1)
- hereditary angioedema, (1)
- high-intensity focused ultrasound ablation (1)
- highly parallel recordings (1)
- histone modification (1)
- hospital (1)
- human intracranial recordings (1)
- hypertonic (1)
- hypoxia (1)
- immune escape (1)
- immune surveillance of cancer (1)
- immunology (1)
- imported malaria (1)
- individualized therapy (1)
- infection eradication (1)
- inflammation (1)
- influenza vaccination (1)
- information storage (1)
- inheritance (1)
- innate immune system (1)
- insecticide (1)
- intensive care (1)
- interleukins (1)
- irbesartan (1)
- isradipine (1)
- kutane Larva migrans (1)
- l-DOPA (1)
- leukemia initiating cell (1)
- liver (1)
- local information dynamics (1)
- local radiotherapy (1)
- long-term prophylaxis (1)
- mRNA vaccine (1)
- mTOR (1)
- macular hole (1)
- malaria elimination (1)
- mandatory reporting (1)
- medical education (1)
- medical teacher (1)
- melanoma (1)
- metastatic cancer (1)
- metastatic melanoma stage IV (1)
- miRNA (1)
- miRNA let-7e (1)
- microRNA (1)
- microplasmin (1)
- microtubule-targeting agents (1)
- monkeys (1)
- motifs (1)
- mouse (1)
- multidrug resistance (1)
- multiunit activity (1)
- mutually exclusive mutations (1)
- natural compounds (1)
- natural product (1)
- neocortex development (1)
- network topology (1)
- neural dynamics (1)
- neuroprotection (1)
- next generation sequencing (1)
- non-small cell lung cancer (1)
- nonrandom connectivity (1)
- ocriplasmin (1)
- oral anticoagulation (1)
- p16 (1)
- p21 (1)
- p53 (1)
- patient-reported outcomes (1)
- peginterferon-α (1)
- pharmacologic vitreolysis (1)
- phase II trial (1)
- polishing (1)
- population-based surveillance (1)
- posterior vitreous detachment (1)
- predictive biomarkers (1)
- predictive coding (1)
- pregnancy (1)
- productivity (1)
- prostate cancer cells (1)
- protein stability (1)
- pulmonary hypertension (1)
- qualitative research (1)
- quality of life (1)
- radiation (1)
- radionuclide imaging (1)
- reactive oxygen species (1)
- recommendations (1)
- recurrent mutations (1)
- remodelling (1)
- resistance (1)
- resource utilization (1)
- resuscitation (1)
- ribavirin (1)
- ribosome-inactivating protein (1)
- rivaroxaban (1)
- roughness (1)
- scientometry (1)
- self-administration (1)
- self-organized criticality (1)
- senescence (1)
- shock (1)
- short-term prophylaxis (1)
- simeprevir (1)
- simulation (1)
- skin inflammation (1)
- smoking (1)
- social cognitive (1)
- solitary pulmonary nodule (1)
- spike train analysis (1)
- spiking neural networks (1)
- spindle assembly (1)
- stage II/III colorectal cancer (1)
- subventricular zone (SVZ) (1)
- sympathetic nervous system (1)
- t(6;9) (1)
- the allen institute for brain science (1)
- therapy (1)
- thyroid nodule (1)
- training (1)
- transarterial chemoembolization (TACE) (1)
- transbronchial biopsy (TBB) (1)
- triple therapy (1)
- tumor infiltrating lymphocytes (1)
- tumor necrosis factor receptor superfamily member 9 (1)
- tumor response (1)
- tumor suppressor (1)
- tumor-specific antigen expressing dendritic cells (1)
- ubiquitin (1)
- vector (1)
- veneering porcelain (1)
- ventricular zone (VZ) (1)
- visual system (1)
- vitreomacular traction (1)
- voltage sensitive dye imaging (1)
- γH2AX (1)
Institute
Endoscopic retrograde cholangiopancreatography (ERCP) offers an effective interventional option for treating symptomatic chronic pancreatitis. Endoscopic pancreatic sphincterotomy is performed to facilitated endoscopic treatment. Pancreatic duct strictures can be treated by inserting plastic stents, and a 10 Fr endoprosthesis is adequate in many cases. Before stent insertion, hydrostatic balloon dilation is needed in some cases. Pancreatic stones can be removed with a dormia basket, but combining ERCP and extracorporeal shockwave lithotripsy (ESWL) is often most effective.
Standard and advanced endoscopic treatment approaches are delineated in this article and include stricture dilation with a Soehendra retriever, cSEMS placement and multi-stenting.
OBJECTIVES: Outcome of aortic valve replacement may be influenced by the choice of bioprosthesis. Pericardial heart valves are described to have a favourable haemodynamic profile compared with porcine valves, although the clinical notability of this finding is still controversially debated. Herein, we compared the long-term results of two commonly implanted bioprosthesis at a single centre.
METHODS: All consecutive patients undergoing isolated aortic valve replacement with either a Carpentier-Edwards Magna pericardial prosthesis or a Medtronic Mosaic porcine prosthesis between 2002 and 2008 were analysed regarding preoperative characteristics, short- and long-term survival, valve-related complications and echocardiographic findings.
RESULTS: The Medtronic Mosaic was implanted in 163 patients and the Carpentier-Edwards Magna in 295 patients. The sizes of implanted valves were 22.4 ± 1.5 mm for the Mosaic and 21.8 ± 1.8 mm for the Magna (P = 0.001). The long-term survival rate was 76 and 56% after 5 and 10 years for the Medtronic Mosaic, which was comparable with the Carpentier-Edwards Magna (77 and 57%; P = 0.92). Overall long-term survival was comparable with an age- and sex-matched Austrian general population for both groups. Valve-related adverse events were similar between groups. The postoperative mean transvalvular gradient was significantly increased in the Mosaic group (24 ± 9 mmHg vs 17 ± 7 mmHg; P < 0.001).
CONCLUSIONS: Both types of aortic bioprostheses offer excellent results after isolated aortic valve replacement. Despite relevant differences in gradients, long-term survival was comparable with the expected normal survival for both bioprostheses. Patients with a porcine heart valve had a higher postoperative transvalvular gradient.
Dendritic cells (DCs) are the cutting edge in innate and adaptive immunity. The major functions of these antigen-presenting cells are the capture, endosomal processing and presentation of antigens, providing them an exclusive ability to provoke adaptive immune responses and to induce and control tolerance. Immature DCs capture and process antigens, migrate towards secondary lymphoid organs where they present antigens to naive T cells in a well-synchronized sequence of procedures referred to as maturation. Indeed, recent research indicated that sphingolipids are modulators of essential steps in DC homeostasis. It has been recognized that sphingolipids not only modulate the development of DC subtypes from precursor cells but also influence functional activities of DCs such as antigen capture, and cytokine profiling. Thus, it is not astonishing that sphingolipids and sphingolipid metabolism play a substantial role in inflammatory diseases that are modulated by DCs. Here we highlight the function of sphingosine 1-phosphate (S1P) on DC homeostasis and the role of S1P and S1P metabolism in inflammatory diseases.
Background: Hereditary angioedema (HAE) due to C1 inhibitor deficiency is a rare but serious and potentially life-threatening disease marked by spontaneous, recurrent attacks of swelling. The study objective was to characterize direct and indirect resource utilization associated with HAE from the patient perspective in Europe.
Methods: The study was conducted in Spain, Germany, and Denmark to assess the real-world experience of HAE via a cross-sectional survey of HAE patients, including direct and indirect resource utilization during and between attacks for patients and their caregivers over the past 6 months. A regression model examined predictors of medical resource utilization.
Results: Overall, 164 patients had an attack in the past 6 months and were included in the analysis. The most significant predictor of medical resource utilization was the severity of the last attack (OR 2.6; p < 0.001). Among patients who sought medical care during the last attack (23%), more than half utilized the emergency department. The last attack prevented patients from their normal activities an average of 4-12 hours. Patient and caregiver absenteeism increased with attack severity and frequency. Among patients who were working or in school (n = 120), 72 provided work/school absenteeism data, resulting in an estimated 20 days missing from work/school on average per year; 51% (n = 84) indicated that HAE has hindered their career/educational advancement.
Conclusion: HAE poses a considerable burden on patients and their families in terms of direct medical costs and indirect costs related to lost productivity. This burden is substantial at the time of attacks and in between attacks.
ND3, ND1 and 39kDa subunits are more exposed in the de-active form of bovine mitochondrial complex I
(2014)
An intriguing feature of mitochondrial complex I from several species is the so-called A/D transition, whereby the idle enzyme spontaneously converts from the active (A) form to the de-active (D) form. The A/D transition plays an important role in tissue response to the lack of oxygen and hypoxic deactivation of the enzyme is one of the key regulatory events that occur in mitochondria during ischaemia. We demonstrate for the first time that the A/D conformational change of complex I does not affect the macromolecular organisation of supercomplexes in vitro as revealed by two types of native electrophoresis. Cysteine 39 of the mitochondrially-encoded ND3 subunit is known to become exposed upon de-activation. Here we show that even if complex I is a constituent of the I+III2+IV (S1) supercomplex, cysteine 39 is accessible for chemical modification in only the D-form. Using lysine-specific fluorescent labelling and a DIGE-like approach we further identified two new subunits involved in structural rearrangements during the A/D transition: ND1 (MT-ND1) and 39kDa (NDUFA9). These results clearly show that structural rearrangements during de-activation of complex I include several subunits located at the junction between hydrophilic and hydrophobic domains, in the region of the quinone binding site. De-activation of mitochondrial complex I results in concerted structural rearrangement of membrane subunits which leads to the disruption of the sealed quinone chamber required for catalytic turnover.
Background: Risk stratification, detection of minimal residual disease (MRD), and implementation of novel therapeutic agents have improved outcome in acute lymphoblastic leukemia (ALL), but survival of adult patients with T-cell acute lymphoblastic leukemia (T-ALL) remains unsatisfactory. Thus, novel molecular insights and therapeutic approaches are urgently needed.
Methods: We studied the impact of B-cell CLL/lymphoma 11b (BCL11b), a key regulator in normal T-cell development, in T-ALL patients enrolled into the German Multicenter Acute Lymphoblastic Leukemia Study Group trials (GMALL; n = 169). The mutational status (exon 4) of BCL11b was analyzed by Sanger sequencing and mRNA expression levels were determined by quantitative real-time PCR. In addition gene expression profiles generated on the Human Genome U133 Plus 2.0 Array (affymetrix) were used to investigate BCL11b low and high expressing T-ALL patients.
Results: We demonstrate that BCL11b is aberrantly expressed in T-ALL and gene expression profiles reveal an association of low BCL11b expression with up-regulation of immature markers. T-ALL patients characterized by low BCL11b expression exhibit an adverse prognosis [5-year overall survival (OS): low 35% (n = 40) vs. high 53% (n = 129), P = 0.02]. Within the standard risk group of thymic T-ALL (n = 102), low BCL11b expression identified patients with an unexpected poor outcome compared to those with high expression (5-year OS: 20%, n = 18 versus 62%, n = 84, P < 0.01). In addition, sequencing of exon 4 revealed a high mutation rate (14%) of BCL11b.
Conclusions: In summary, our data of a large adult T-ALL patient cohort show that low BCL11b expression was associated with poor prognosis; particularly in the standard risk group of thymic T-ALL. These findings can be utilized for improved risk prediction in a significant proportion of adult T-ALL patients, which carry a high risk of standard therapy failure despite a favorable immunophenotype.
Glioblastoma multiforme (GBM) is a deadly primary brain malignancy. Glioblastoma stem cells (GSC), which have the ability to self-renew and differentiate into tumor lineages, are believed to cause tumor recurrence due to their resistance to current therapies. A subset of GSCs is marked by cell surface expression of CD133, a glycosylated pentaspan transmembrane protein. The study of CD133-expressing GSCs has been limited by the relative paucity of genetic tools that specifically target them. Here, we present CD133-LV, a lentiviral vector presenting a single chain antibody against CD133 on its envelope, as a vehicle for the selective transduction of CD133-expressing GSCs. We show that CD133-LV selectively transduces CD133+ human GSCs in dose-dependent manner and that transduced cells maintain their stem-like properties. The transduction efficiency of CD133-LV is reduced by an antibody that recognizes the same epitope on CD133 as the viral envelope and by shRNA-mediated knockdown of CD133. Conversely, the rate of transduction by CD133-LV is augmented by overexpression of CD133 in primary human GBM cultures. CD133-LV selectively transduces CD133-expressing cells in intracranial human GBM xenografts in NOD.SCID mice, but spares normal mouse brain tissue, neurons derived from human embryonic stem cells and primary human astrocytes. Our findings indicate that CD133-LV represents a novel tool for the selective genetic manipulation of CD133-expressing GSCs, and can be used to answer important questions about how these cells contribute to tumor biology and therapy resistance.
Background: Evaluation of automated attenuation-based tube potential selection and its impact on image quality and radiation dose in CT (computed tomography) examinations for cancer staging.
Methods: A total of 110 (59 men, 51 women) patients underwent chest-abdomen-pelvis CT examinations; 55 using a fixed tube potential of 120 kV/current of 210 Reference mAs (using CareDose4D), and 55 using automated attenuation-based tube potential selection (CAREkV) also using a current of 210 Reference mAs. This evaluation was performed as a single-centre, observer-blinded retrospective analysis. Image quality was assessed by two readers in consensus. Attenuation, image noise, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) were measured or calculated for objective image evaluation. For the evaluation of radiation exposure, dose-length-product (DLP) values were compared and Size-specific dose estimates (SSDE) values were calculated.
Results: Diagnostic image quality was obtained from all patients. The median DLP (703.5 mGy · cm, range 390–2203 mGy · cm) was 7.9% lower when using the algorithm compared with the standard 120 kV protocol (median 756 mGy · cm, range 345–2267 mGy · cm). A reduction in potential to 100 kV occurred in 32 cases; therefore, these patients received significantly lower radiation exposure compared with the 120 kV protocol.
Conclusion: Automated attenuation-based tube potential selection produces good diagnostic image quality in chest-abdomen-pelvis CT and reduces the patient’s overall radiation dose by 7.9% compared to the standard 120 kV protocol.
Escherichia coli α-hemolysin (HlyA) is a pore-forming protein of 110 kDa belonging to the family of RTX toxins. A hydrophobic region between the amino acid residues 238 and 410 in the N-terminal half of HlyA has previously been suggested to form hydrophobic and/or amphipathic α-helices and has been shown to be important for hemolytic activity and pore formation in biological and artificial membranes. The structure of the HlyA transmembrane channel is, however, largely unknown. For further investigation of the channel structure, we deleted in HlyA different stretches of amino acids that could form amphipathic β-strands according to secondary structure predictions (residues 71–110, 158–167, 180–203, and 264–286). These deletions resulted in HlyA mutants with strongly reduced hemolytic activity. Lipid bilayer measurements demonstrated that HlyAΔ71–110 and HlyAΔ264–286 formed channels with much smaller single-channel conductance than wildtype HlyA, whereas their channel-forming activity was virtually as high as that of the wildtype toxin. HlyAΔ158–167 and HlyAΔ180–203 were unable to form defined channels in lipid bilayers. Calculations based on the single-channel data indicated that the channels generated by HlyAΔ71–110 and HlyAΔ264–286 had a smaller size (diameter about 1.4 to 1.8 nm) than wildtype HlyA channels (diameter about 2.0 to 2.6 nm), suggesting that in these mutants part of the channel-forming domain was removed. Osmotic protection experiments with erythrocytes confirmed that HlyA, HlyAΔ71–110, and HlyAΔ264–286 form defined transmembrane pores and suggested channel diameters that largely agreed with those estimated from the single-channel data. Taken together, these results suggest that the channel-forming domain of HlyA might contain β-strands, possibly in addition to α-helical structures.
Zu den exzellenten Frankfurter Neurowissenschaftlern des 20. Jahrhunderts zählt Kurt Goldstein. Er durchlief die harte Schule von Ludwig Edinger. Bekannt wurde er jedoch durch einen eigenständigen Ansatz, der mit dem Schlagwort ganzheitliche Neurologie charakterisiert werden kann. Er wandte sich gegen die Auffassung, »Funktionen« im Gehirn exakt lokalisieren zu können, ohne den lokalisatorischen Ansatz vollständig zu verwerfen. Besondere Aufmerksamkeit schenkte er den Kompensationsreaktionen des Gehirns und des »ganzen« Menschen. » […] he never forgot that he addressed an individual, not a brain«, brachte es sein Schüler Walther Riese auf den Punkt.